Nexxa.ai | $4,400,000 | (Jul 22, 2025)
Litero AI | $800,000 | (Jul 22, 2025)
Ovasave | $1,200,000 | (Jul 22, 2025)
Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
Radical AI | $55,000,000 | (Jul 22, 2025)
LeadStory | $2,750,000 | (Jul 22, 2025)
Xelix | $160,000,000 | (Jul 22, 2025)
Toduba | $4,090,457 | (Jul 22, 2025)
Alix | $20,000,000 | (Jul 22, 2025)
WattCarbon | Undisclosed Amount | (Jul 18, 2025)
Occupi | $3,000,000 | (Jul 18, 2025)
Folio | $14,000,000 | (Jul 18, 2025)
BQP(US) | $5,000,000 | (Jul 18, 2025)